Since the EGFR has been reported to promote prostate cancer metastasis to bone by down-regulating miR-1 [19], we further investigated whether ADAM9 may suppress miR-1 expression by activating EGFR signaling. This evidence concerns the gene ADAM9 and prostate cancer.